The Long Run with Luke Timmerman cover image

The Long Run with Luke Timmerman

Ep139: Kevin Conroy on Early Detection of Cancer

Jul 10, 2023
01:08:28

Podcast summary created with Snipd AI

Quick takeaways

  • Exact Sciences enhances cancer screening with non-invasive tests like Cologuard, reducing false positives.
  • Acquisition of Genomic Health guides breast cancer treatment based on genetic markers.

Deep dives

Transforming Cancer Screening with Cologuard and Oncotype DX Tests

Exact Sciences has revolutionized cancer screening with its non-invasive Cologuard test, detecting colorectal cancer with a significant reduction in false positive rates. Additionally, through the acquisition of Genomic Health and its Oncotype DX test, Exact Sciences has expanded its reach to guide breast cancer treatment decisions based on genetic markers. The company's focus on improving early cancer detection and prediction of treatment benefits underscores its mission to advance diagnostic accuracy and patient outcomes.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner